Business Model Options for Antibiotics

24th February 2015

Authors: E. Jaczynska, K. Outterson, and J. Mestre-Ferrandiz

Big Innovation Centre and Chatham House co-created a report offering a number of innovative business models and funding structure ideas that address many of the critical questions facing investment in antibiotics. The report hopes to help funders, policy-makers, the pharma industry, Research Councils and academia in the EU and the US as they seek solutions to the misalignment between the need for new antibiotics and the incentives, or lack thereof, for their development.

Many of the recommendations will feed in to ongoing initiatives and programmes working on creating the final solutions.

The report is online here.

The appendices are online here